Sale!

BALVERSA Drug Profile, 2024

Original price was: $800.00.Current price is: $399.00.

BALVERSA (erdafitinib) drug patents, clinical trials, drug prices, suppliers, API sources

SKU: BALVERSA Category:
Originally published at https://www.chemintel360.com/. Get our excipient business reports at https://chemintel360.com/product-category/excipients/, and our drug patent reports at https://chemintel360.com/product-category/drug-patent-reports/

BALVERSA Drug Profile, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

This definitive guide provides invaluable business insights into every crucial aspect of this medication, addressing the vital points necessary to make business decisions.

Gain key critical insights for BALVERSA:

  • United States patents
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
Pages

60

Product

BALVERSA

ChemIntel360
Scroll to Top